异柠檬酸脱氢酶（IDH）突变型髓系肿瘤与血清阴性类风湿性关节炎及固有免疫激活相关。
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.
作者信息
Hong Lih En, Wechalekar Mihir D, Kutyna Monika, Small Annabelle, Lim Kelly, Thompson-Peach Chloe, Li Joule J, Chhetri Rakchha, Scott Hamish S, Brown Anna, Hahn Christopher N, Yeung David T, Sajid Salvia, Robinson Nirmal, Thomas Ranjeny, Branford Susan, D'Andrea Richard J, Samaraweera Saumya E, Patnaik Mrinal, Proudman Susanna, Thomas Daniel, Kok Chung Hoow, Shah Mithun V, Hiwase Devendra K
机构信息
Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia.
Adelaide Medical School, University of Adelaide, Adelaide, Australia.
出版信息
Blood. 2024 May 2;143(18):1873-1877. doi: 10.1182/blood.2023023593.
High prevalence of IDH mutations in seronegative rheumatoid arthritis (RA) with myeloid neoplasm, elevated 2-hydroxyglutarate, dysregulated innate immunity, and proinflammatory microenvironment suggests causative association between IDH mutations and seronegative RA. Our findings merit investigation of IDH inhibitors as therapeutics for seronegative IDH-mutated RA.
在伴有髓系肿瘤、2-羟基戊二酸升高、先天免疫失调和促炎微环境的血清阴性类风湿性关节炎（RA）中，异柠檬酸脱氢酶（IDH）突变的高发生率表明IDH突变与血清阴性RA之间存在因果关联。我们的研究结果值得对IDH抑制剂作为血清阴性IDH突变型RA的治疗方法进行研究。
Zotero 插件